In patients with heart failure with preserved ejection fraction (HFpEF), β-blocker use was not associated with concurrent ...

The FDA cleared a subcutaneous maintenance version of lecanemab, allowing patients with AD (Alzheimer’s disease) to continue ...

Between the years 2017 and 2023, the proportion of total computed tomographic angiography (CTA) examinations related to ...

In adult patients with Crohn’s disease (CD) treated with risankizumab, only 13% of patients experienced treatment failure ...

Novo’s srRNA push expands cardiometabolic pipeline On August 28, Novo Nordisk announced a collaboration with Replicate ...

Novo Nordisk expanded into self replicating RNA for obesity and T2D (type 2 diabetes), signaling modality diversification beyond peptides. 2. The collaboration with Replicate Bioscience includes ...

In pretreated patients with nucleophosmin 1-mutated (NPM1m) acute myeloid leukemia (AML), nearly half of patients treated ...

In this large global cohort study, individuals aged 50 without five major cardiovascular risk factors (hypertension, ...

In this randomized controlled trial, among adults with HER2-positive unresectable or metastatic gastric cancer who had ...

In this randomized controlled trial, among adults with obesity, it was found that tirzepatide resulted in a significantly ...

Illinois bans unsupervised AI in mental health care Illinois approved the Wellness and Oversight for Psychological Resources ...